Growth Stage: Operational Excellence
There is a moment in every startup's life when the founding team realises something uncomfortable: the skills that got you here will not get you there. Building a product and winning early customers requires creativity, speed, and risk tolerance. Scaling from £10M to £50M ARR requires something different entirely — operational discipline, governance frameworks, and financial rigour that would have felt premature eighteen months ago but are now essential to survival.
NovaTech has reached this inflection point. With £22M ARR, 82% gross margins, and a team of 120 people, the company is no longer a startup. It is a scale-up, and the operational challenges it faces are fundamentally different from anything the founders have navigated before.
The growth stage is where startups become real companies. The founders who succeed are those who embrace operational excellence not as a constraint on innovation, but as the foundation that makes sustained innovation possible. Every process you build, every governance framework you implement, every financial discipline you adopt is an intangible asset that compounds your company's value.
Operating Leverage: How SaaS Companies Become Profitable
Operating leverage is the mechanism by which SaaS companies transition from loss-making growth businesses to highly profitable enterprises. It works because software has near-zero marginal cost — once you have built the platform, each additional customer adds revenue but very little incremental cost.
The mathematics are straightforward but powerful. As revenue grows, fixed costs (R&D, G&A, office space) are spread across a larger base. Variable costs (hosting, customer success, payment processing) grow, but more slowly than revenue. The gap between revenue growth and cost growth is operating leverage, and it widens with every percentage point of scale.
NovaTech's current operating margin of -8% might appear concerning in isolation, but the trajectory tells a different story. Twelve months ago, the operating margin was -24%. The improvement came not from cutting costs but from revenue growing faster than expenses. At the current 60% year-on-year growth rate and 72% contribution margins, NovaTech's financial model projects profitability at approximately £35M ARR.
NovaTech's engineering team costs £6.2M annually — roughly 28% of ARR. At £22M ARR, this feels expensive. At £50M ARR (projected within 24 months), the same team — even with modest salary inflation and a few key hires — would cost approximately £7.8M, or just 15.6% of ARR. That 12.4 percentage point improvement drops straight to the operating line. This is operating leverage in action.
The Board's Great Debate: Growth vs Profitability
Every growth-stage company faces a strategic fork in the road. NovaTech's board spent three meetings debating it: should the company accelerate growth by investing the remaining Series B capital aggressively, or should it optimise for profitability to reduce dependence on future fundraising?
Accelerate Growth
- Push for 80%+ YoY growth
- Expand sales team from 20 to 35 reps
- Enter US market 6 months earlier
- Requires Series C within 18 months
- Higher valuation but more dilution
Optimise for Profitability
- Maintain 60% YoY growth
- Reach breakeven at £35M ARR
- Optional Series C from position of strength
- Lower dilution, more founder control
- Risk: competitors may outpace in market capture
The answer depends on market dynamics. In NovaTech's case, the AI supply chain analytics market was consolidating rapidly. Two competitors had also raised significant rounds. The board chose a middle path: maintain 60% growth while driving towards profitability, but reserve the option to accelerate if competitive dynamics demanded it. This required operational excellence — doing more with less, rather than simply spending more.
R&D Capitalisation: When Development Becomes an Asset
One of the most significant financial decisions at the growth stage is whether to capitalise research and development costs. Under IAS 38 — the international accounting standard governing intangible assets — certain development expenditure can be recognised as an asset on the balance sheet rather than expensed through the profit and loss account.
This is not merely an accounting choice. It changes how investors, lenders, and acquirers perceive your business. A company that capitalises qualifying R&D shows higher operating profit (because costs are amortised over years rather than expensed immediately) and carries an intangible asset on its balance sheet that represents the economic value of its technology investment.
R&D capitalisation under IAS 38 is not optional or discretionary. It is mandatory when all six recognition criteria are met. Companies cannot choose to capitalise in good years and expense in bad years — that would be earnings manipulation. If you meet the criteria, you must capitalise. If you do not meet them, you must expense.
The Six IAS 38 Capitalisation Criteria
To capitalise development expenditure, a company must demonstrate all six of the following simultaneously:
1. Technical feasibility
The company must demonstrate that completing the intangible asset is technically feasible. For software, this typically means the product has passed proof-of-concept and the core technical challenges have been resolved.
2. Intention to complete
Management must have a clear intention to complete the asset and use or sell it. Board minutes, product roadmaps, and resource allocation plans serve as evidence.
3. Ability to use or sell
The company must have the resources and capability to complete development. This includes sufficient funding, skilled personnel, and necessary infrastructure.
4. Future economic benefits
The asset must be expected to generate probable future economic benefits — typically demonstrated through market research, customer commitments, or revenue projections for the new capability.
5. Adequate resources
Technical, financial, and other resources must be available to complete development and to use or sell the asset. Cash flow projections and headcount plans provide evidence.
6. Reliable measurement
The expenditure attributable to the asset during development must be reliably measurable. Time-tracking systems, project accounting, and cost allocation methodologies are essential.
NovaTech began capitalising development costs on its predictive procurement module once it passed the technical feasibility milestone. Over the next 12 months, £1.8M in qualifying development expenditure was capitalised as an intangible asset and amortised over a 3-year useful life. This shifted £1.2M from opex to the balance sheet in year one, improving the reported operating margin by approximately 5.5 percentage points. For a deeper exploration of this topic, see our guide to AI capitalisation.
Building the Board Reporting Pack
Growth-stage companies need management reporting that serves three audiences: the executive team (operational decisions), the board (strategic oversight), and investors (confidence and transparency). A well-designed board pack is itself an intangible asset — it signals operational maturity and builds trust with stakeholders.
Essential Board Reporting Pack Components
| Section | Contents | Frequency |
|---|---|---|
| Financial Summary | P&L, cash flow, balance sheet, variance to budget | Monthly |
| Revenue Metrics | ARR, NRR, GRR, ACV, pipeline coverage, win rates | Monthly |
| Operational KPIs | Headcount, burn rate, runway, customer health scores | Monthly |
| Product Metrics | Feature adoption, NPS, support ticket volume, uptime | Quarterly |
| Strategic Initiatives | Progress on key projects, risks, mitigations | Quarterly |
| Cap Table & Governance | Option pool usage, board resolutions, compliance status | Quarterly |
The best board packs tell a story, not just present numbers. Each metric should be accompanied by context: what changed, why it changed, and what the team is doing about it. NovaTech's CFO introduced a "three things going well, three things keeping me up at night" executive summary that the board found more valuable than 40 pages of charts.
SOC 2 and ISO 27001: When Compliance Becomes a Revenue Driver
Security certifications start as a cost centre and end as a competitive advantage. The question is not whether your growth-stage company needs SOC 2 or ISO 27001 — it is when. The answer is almost always "earlier than you think."
SOC 2 Type II
- US-centric standard, widely required by enterprise buyers
- Covers security, availability, processing integrity, confidentiality, privacy
- Requires 6–12 month observation period for Type II
- Cost: £30K–£80K for initial audit
- NovaTech trigger: lost 3 enterprise deals requiring SOC 2
ISO 27001
- International standard, essential for European and APAC markets
- Comprehensive information security management system (ISMS)
- Requires documented policies, risk assessments, and controls
- Cost: £25K–£60K for certification
- NovaTech trigger: EU expansion required ISO 27001 for procurement
NovaTech pursued both certifications in parallel, recognising that its enterprise customer base increasingly required one or both. The total investment — including tooling, consultant fees, audit costs, and the time of the internal team — was approximately £180K over 12 months. Within the first quarter after certification, the sales team closed two deals worth £420K combined that had been blocked by compliance requirements. The ROI was immediate and measurable.
Treat compliance certifications as investments in your intangible asset base, not as overhead. SOC 2 and ISO 27001 reduce friction in enterprise sales cycles, lower cyber insurance premiums, and signal operational maturity to acquirers. Begin the process at least 12 months before you expect to need the certification.
EMI Share Option Schemes: Aligning the Team
The Enterprise Management Incentive (EMI) scheme is one of the most tax-efficient ways to grant equity to employees in the UK. At the growth stage, a well-designed EMI scheme becomes a critical tool for attracting senior hires, retaining key talent, and aligning the entire team around long-term value creation.
EMI options allow employees to acquire shares at a pre-agreed exercise price. If the company is eventually sold for more than the exercise price, employees pay Capital Gains Tax (currently 20% for higher-rate taxpayers) rather than Income Tax (up to 45%) on the difference. Business Asset Disposal Relief can further reduce CGT to 10% on the first £1M of lifetime gains.
NovaTech EMI Scheme Design
| Parameter | NovaTech Design | Typical Range |
|---|---|---|
| Total option pool | 500,000 shares | 10–15% of fully diluted equity |
| Eligible employees | 45 of 120 staff | Senior + high-impact roles |
| Exercise price | £0.30 (HMRC valuation) | Agreed with HMRC via Advance Assurance |
| Market value reference | £1.20 per share (Series B implied) | Based on last funding round |
| Vesting schedule | 4 years, 1-year cliff | 3–4 years with cliff |
| Good leaver provisions | Vested options exercisable for 90 days | 30–180 days |
| Bad leaver provisions | All options (vested and unvested) lapse | Standard |
Sarah, NovaTech's VP of Engineering, was granted 25,000 EMI options at the £0.30 exercise price. If NovaTech is acquired for a price implying £4.00 per share, Sarah's options would be worth (£4.00 − £0.30) × 25,000 = £92,500 in pre-tax gain. Under EMI with Business Asset Disposal Relief, she would pay 10% CGT — £9,250 — keeping £83,250. Had the same benefit been delivered as a cash bonus, she would pay up to 45% Income Tax plus National Insurance, netting roughly £50,000. The EMI structure delivers 66% more value to the employee at no additional cost to the company.
The exercise price differential — £0.30 versus £1.20 — reflects HMRC's acceptance that options over unquoted shares should be valued using an earnings or net asset basis that accounts for minority discounts and lack of marketability, rather than the headline price-per-share implied by a venture capital round. NovaTech obtained Advance Assurance from HMRC confirming the £0.30 valuation before granting any options, eliminating the risk of a retrospective challenge. For a deeper dive into structuring equity incentives, see our equity incentives guide.
NovaTech at the Growth Stage: Putting It All Together
The transition from startup to scale-up is fundamentally about building operational assets that compound. NovaTech's journey through the growth stage illustrates how each decision — from R&D capitalisation to compliance certification to EMI scheme design — creates a layer of intangible value that strengthens the business for whatever comes next.
NovaTech Growth Stage Scorecard
£22M ARR with 82% gross margins and a clear path to profitability at £35M ARR. Operating leverage improving quarterly. R&D capitalisation adding £1.8M to the balance sheet. SOC 2 Type II and ISO 27001 certifications unlocking enterprise deals. An EMI scheme aligning 45 key employees with long-term value creation. The company is no longer just building a product — it is building a machine that builds value.
The intangible assets NovaTech has accumulated — its technology platform, customer relationships, brand recognition, organisational processes, and now its governance and compliance frameworks — represent the vast majority of the company's enterprise value. Understanding how to measure and communicate these assets is what separates companies that achieve premium valuations from those that leave value on the table. Opagio's Growth Platform is designed to help companies at exactly this stage quantify their intangible asset base and communicate it effectively to investors, acquirers, and lenders.
Every system you implement, every certification you earn, every governance framework you adopt is an intangible asset that compounds your company's value. The founders who recognise this — who treat operational excellence as asset creation rather than bureaucratic overhead — are the ones who build companies worth acquiring.
This is Lesson 6 of 8 in the Startup Mastery series: From Idea to Exit. Next lesson: Pre-Exit — Preparing the Business for Sale.
About the Author
Mark Hillier is CCO of Opagio, where he leads commercial strategy and growth initiatives. With extensive experience in PE exit preparation, commercial due diligence, and scaling B2B businesses, Mark brings a commercial operator's perspective to startup growth strategy. Meet the team →